MILWAUKEE – The Society for Immunotherapy of Cancer (SITC) is pleased to announce the recipients of three 2019 Fellowship Awards, which support the next generation of cancer immunotherapy and tumor immunology experts through dedicated funding of novel research.
This year’s awards include the SITC-Amgen Cancer Immunotherapy in Hematologic Malignancies Fellowship Award (a one-year, $100,000 award), the SITC-AstraZeneca Immunotherapy in Lung Cancer (Early Stage NSCLC) Clinical Fellowship Award (a one-year, $100,000 award) and SITC's Holbrook Kohrt, MD, PhD Cancer Immunotherapy Translational Memorial Fellowship Award (sponsored by Genentech) (a one-year, $100,000 award).
Read More >>
SITC Communicationscommunications@sitcancer.org+1 414-271-2456
6/11/19 – Oncology News Burst from FDA: pembrolizumab
6/10/19 – Oncology News Burst from FDA: polatuzumab vedotin-piiq
5/31/19 – The Society for Immunotherapy of Cancer Recognizes Cancer Immunotherapy Month™
5/16/19 – Cancer Researchers to Rock Buddy Guy’s Legends for One Night Only
5/16/19 – Oncology News Burst from FDA: Avelumab
4/29/19 – Society for Immunotherapy of Cancer to host back-to-back workshops on cancer immune responsiveness and adoptive cellular therapies
Tel: +1 414 271 2456 | Fax: +1 414 276 3349 | Email: firstname.lastname@example.org